The cost effectiveness of hepatitis immunization for US college students

Journal of the American College Health Association

Volumn 51, Issue 6, 2003, Pages 227-236

  Jacobs, R Jake ^a   Saab, Sammy ^b   Meyerhoff, Allen S ^a  

^a Capitol Outcomes Research   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

College students; Cost and cost analysis; Hepatitis A; Hepatitis B; Immunization

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE;

ACUTE HEPATITIS; ADULT; ARTICLE; CHRONIC HEPATITIS; COLLEGE STUDENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; ECONOMIC ASPECT; HEALTH CARE SYSTEM; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; INFECTION PREVENTION; INFECTION RISK; LONGEVITY; MEDICAL SOCIETY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; UNITED STATES; VACCINATION;

EID: 0141426621     PISSN: 07448481     EISSN: None     Source Type: Journal    
DOI: 10.1080/07448480309596355     Document Type: Article

References (63)

1. CDC. 1999. Notice to readers update:Recommendations to prevent hepatitis B virus transmission-United States. MMWR., 48:33–34.
2. CDC. 1999. Prevention of hepatitis A through active or passive immunization:Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR., 48 (RR-12):1–37.
3. Averhoff, F, Shapiro, C N, and Bell, B P. 2001. Control of hepatitis A through routine vaccination of children. JAMA., 286:2968–2973.
4. CDC. 2002. Hepatitis B vaccination-United States, 1982–2002. MMWR., 51:549–552. 563
5. Margolis, H S, Coleman, P J, Brown, R E. 1995. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA., 274:1201–1208.
6. Krahn, M, Guasparini, R, Sherman, M, and Detsky, A S. 1998. Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program. Am J Public Health., 88:1638–1644.
7. Levaux, H P, Schonfeld, W H, Pellissier, J M. 2001. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents. Pediatrics., 108:317–325.
8. Jacobs, R J, Margolis, H S, and Coleman, P J. 2000. The cost-effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates. Arch Pediatr Adolesc Med., 154:763–770.
9. O'Connor, J B, Imperiale, T F, and Singer, M E. 1999. Cost-effectiveness analysis of hepatitis A vaccination strategies for adults. Hepatology., 30:1077–1081.
10. Bloom, B S, Hillman, A L, Fendrick, A M, and Schwartz, J S. 1993. A reappraisal of hepatitis B virus vaccination using cost-effectiveness analysis. Ann Intern Med., 118:298–306.
11. Beutels, P., 2001. Economic evaluations of hepatitis B immunization:A global review of recent studies (1994–2000). Health Econ., 10:751–774.
12. Rosenthal, P., 2003. Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults. Hepatology, 37:44–51.
13. Pisu, M, Meltzer, M I, and Lyerla, R., 2002. Cost-effectiveness of hepatitis B vaccination of prison inmates. Vaccine., 21:31–321. 2
14. Jacobs, R J, and Meyerhoff, A S. 1999. Vaccination of sexually active homosexual men against hepatitis A:Analysis of costs and benefits. Journal of the Gay and Lesbian Medical Association., 3:51–58.
15. Van Doorslaer, E, Tormans, G, and Van Damme, P., 1994. Cost effectiveness analysis of vaccination against hepatitis A in travelers. J Med Virol., 44:463–469.
16. Jacobs, R J, Koff, R S, and Meyerhoff, A S. 2002. The cost effectiveness of vaccinating chronic hepatitis C patients against hepatitis A. Am J Gastroenterol., 97:427–434.
17. Arguedas, M R, Heudebert, G R, Fallon, M B, and Stinnett, A A. 2002. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States. Am J Gastroenterol., 97:721–728.
18. Ganguly, R, Marty, P J, Herold, A H, and Anderson, M., 1998. Hepatitis B immunization in a university student population. J Am Coll Health., 46:181–183.
19. 2002. Immunization Action Coalition Hepatitis B prevention mandates. Available at:http://www.immunize.org/laws/hepb.htm. Accessed February
20. American College Health Association. 2003. Recommendations for institutional prematriculation immunizations Available at:http://www.acha.org/info_resources/RIPIstatement.pdf. Accessed February
21. Goldstein, S T, Alter, M J, Williams, I T. 2002. Incidence and risk factors for acute hepatitis B in the United States, 1982–1998:Implications for vaccination programs. J Infect Dis., 185:713–719.
22. Armstrong, G L, and Bell, B P. 2002. Hepatitis A infections in the United States:Model-based estimates and implications for childhood immunization. Pediatrics., 109:839–845.
23. 2002. US Census Bureau. The official statistics Available at:http://www.census.gov/pub/population/estimates. Accessed May
24. CDC. 2000. Hepatitis Surveillance Report Number 57, Atlanta, GA:Centers for Disease Control and Prevention.
25. Coleman, P J, McQuillan, G M, Moyer, L A. 1998. Incidence of hepatitis B virus infection in the United States, 1976–1994:Estimates from the National Health and Nutrition Examination Surveys. J Infect Dis., 178:954–959.
26. US Census Bureau. 2002. Attendance status of college students 15 years old and over, by age, sex, year and type of college, race, and Hispanic origin Available at:http://www.census.gov/population/socdemo/school/ppl148/tab10.xls. Accessed May
27. Berge, J J, Drennan, D P, Jacobs, R J. 2000. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology., 31:469–473.
28. Krahn, M, and Detsky, A S. 1993. Should Canada and the United States universally vaccinate infants against hepatitis B?. Med Decis Making., 13:4–20.
29. Fendrick, A M, Lee, J H, LaBarge, C. 1999. Clinical and economic impact of a combination haemophilus influenzae and hepatitis B vaccine. Arch Pediatr Adolesc Med., 153:126–136.
30. 2003. Centers for Disease Control and Prevention. CDC vaccine price list Available at:http://www.cdc.gov/nip/vfc/cdc_vac_price_list.htm. Accessed March 8
31. National Center for Education Statistics. 2002. Total undergraduate enrollment in all degree-granting institutions, by sex, attendance status, and control of institution Available at:http://nces.ed.gov/pubs2001/proj01/tables/table19.asp. Accessed May
32. Jacobs, R J, and Meyerhoff, A S. 2003. Effect of middle school entry requirements on adolescent hepatitis b immunization. Presented at the Pediatric Academic Societies Annual Meeting; Seattle, WA May, [abstract 1748]
33. Joines, R W, Blatter, M, Abraham, B. 2001. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults. Vaccine., 19:4710–4719.
34. Rendi-Wagner, P, Kundi, M, Stemberger, H. 2001. Antibody response to three recombinant hepatitis B vaccines:Comparative evaluation of multicenter travel-clinic based experience. Vaccine., 19:2055–2060.
35. Clemens, R, Safary, A, Hepburn, A, Roche, C, Stanbury, W J, and André, F E. 1995. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis., 171 (suppl 1):S44–S49.
36. West, D J, and Calandra, G B. 1996. Vaccine induced immunologic memory for hepatitis B surface antigen:Implications for policy on booster vaccination. Vaccine., 14:1019–1027.
37. Meyerhoff, A S, Greenberg, D P, and Jacobs, R J. 2001. Cost-effectiveness of adolescent hepatitis B public health policies and 2- versus 3-dose vaccination regimens. Pediatric Research., 49:151A
38. Crosby, O., 2002. “ Degrees to dollars:Earnings of college graduates in 1998. ”. In Occupational Outlook Quarterly. Winter 2000–01 Available at:http://www.bls.gov/opub/ooq. Accessed May
39. Walker, M AC, and Bergman, B J. 1999. Analyzing year-to-year changes in employer costs for employee compensation. Compensation and Working Conditions.,:19–27. Spring
40. Saunders, N C, and Su, B W. 1999. “ The US economy to 2008:A decade of continued growth. ”. In Monthly Labor Review, Washington, DC:Bureau of Labor Statistics. November.
41. Jacobs, R J, Moleski, R J, and Meyerhoff, A S. 2002. The value of hepatitis A prevention based on time tradeoff and willingness-to-pay measurement. Pharmacoeconomics., 20:739–747.
42. Younossi, Z M, Boparai, N, McCormick, M. 2001. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol., 96:579–583.
43. Kim, W R, Poterucha, J J, Hermans, J E. 1997. Costeffectiveness of 6 and 12 months of interferon therapy for chronic hepatitis C. Ann Intern Med., 127:866–874.
44. Bennett, W G, Inoue, Y, Beck, J R. 1997. Estimates of the cost-effectiveness of a single course of interferon-2b in patients with histologically mild chronic hepatitis C. Ann Intern Med., 127:855–865.
45. US Bureau of Labor Statistics. 2002. Consumer price index-All urban consumers Available at:http://www.bls.gov/cpi/home.htm. Accessed May
46. US Bureau of Labor Statistics. 2002. Employment Cost Index Available at:http://www.bls.gov/ect/home.htm. Accessed May
47. Weinstein, M C, Siegel, J E, Gold, M E. 1996. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA., 276:1253–1258.
48. Jacobs, R J, and Meyerhoff, A S. 2001. Comparative cost effectiveness of varicella, hepatitis A and pneumococcal conjugate vaccines. Prev Med., 33:639–645.
49. Marron, R L, Lanphear, B P, Kouides, R. 1998. Efficacy of informational letters on hepatitis B immunization rates in university students. J Am Coll Health., 47:123–127.
50. Hurley, J L, Turner, H S, and Butler, K M. 2001. Planning and execution of a successful hepatitis B immunization program. J Am Coll Health., 49:189–191.
51. Laupacis, A, Feeny, D, Detsky, A S, and Tugwell, P X. 1992. How attractive does a new technology have to be to warrant adoption and utilization?. CMAJ., 146:473–481.
52. Tengs, T O, Adams, M E, Pliskin, J S. 1995. Five-hundred lifesaving interventions and their cost-effectiveness. Risk Analysis., 15:369–390.
53. Stone, P W, Teutsch, S, Chapman, R H. 2000. Cost-utility analyses of clinical preventive services:Published ratios, 1976–1997. Am J Prev Med., 19:15–23.
54. Bell, B P. 2002. Hepatitis A vaccine. Semin Pediatr Infect Dis., 13:165–173.
55. Hadler, S C, and Margolis, H S. 1992. Hepatitis B immunizations:vaccine types, efficacy, and indications for immunization. Cur Clin Top Infect Dis., 12:292–308.
56. Jackson, L A, Schuchat, A, Gorsky, R D, and Wenger, J D. 1995. Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. Am J Public Health., 85:843–845.
57. DiClemente, R, Forrest, K, and Mickler, S., 1990. College students' knowledge and attitudes about AIDS and changes in HIV-related behaviors. AIDS Educ Prev., 2:201–212.
58. Douglas, K A, Collins, J L, Warren, C. 1997. Results from the 1995 College Health Risk Behavior Survey. J Am Coll Health., 46:55–66.
59. Eisenberg, M., 2001. Differences in sexual risk behaviors between college students with same sex and opposite sex experience:Results from a national survey. Arch Sex Behav., 30:575–589.
60. Gilbert, L, and Alexander, L., 1998. A profile of sexual health behaviors among college women. Psychol Rep., 82:107–116.
61. Staes, C J, Schlenker, T L, Risk, I. 2000. Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics., 106:E54
62. Wilson, B C, Moyer, L A, Schmid, G. 2001. Hepatitis B vaccination in sexually transmitted disease (STD) clinics:A survey of STD programs. Sex Transmit Dis., 28:148–152.
63. Margolis, H S, Handsfield, H H, Jacobs, R J, and Gangi, J., 2000. Office-based intervention to improve vaccination status of patients at risk for sexual transmission of hepatitis B virus infection. Am J Obstet Gynecol., 182:1–6.